✦ LIBER ✦

CREON®: efficacy and safety in children less than 7 years old with exocrine pancreatic insufficiency due to cystic fibrosis

✍ Scribed by S. Sander-Struckmeier; D. Boyd; S.D. Caras

Book ID: 118642321
Publisher: Elsevier Science
Year: 2009
Tongue: English
Weight: 57 KB
Volume: 8
Category: Article
ISSN: 1569-1993
DOI: 10.1016/s1569-1993(09)60315-5

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Efficacy and safety of Creon® 24,000 in

Efficacy and safety of Creon® 24,000 in subjects with exocrine pancreatic insufficiency due to cystic fibrosis

✍ Bruce C. Trapnell; Karen Maguiness; Gavin R. Graff; David Boyd; Katrin Beckmann; 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 422 KB

Efficacy and safety of a new formulation

Efficacy and safety of a new formulation of CREON® in patients with exocrine pancreatic insufficiency due to CF

✍ B.C. Trapnell; K. Maguiness; G.R. Graff; D. Boyd; S.D. Caras; K. Beckmann; D. Be 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 57 KB

Safety and Tolerability of a New Formula

Safety and Tolerability of a New Formulation of Pancrelipase Delayed-Release Capsules (CREON®) in Children Under Seven Years of Age with Exocrine Pancreatic Insufficiency due to Cystic Fibrosis

✍ , Prof. Gavin R. Graff Professor and Chief Pediatric Pulmonology, John McNamara, 📂 Article 📅 2010 🏛 Springer International Publishing AG 🌐 English ⚖ 179 KB

S2059 Efficacy and Safety of Pancrelipas

S2059 Efficacy and Safety of Pancrelipase Delayed-Release Capsules in Patients with Pancreatic Insufficiency Due to Cystic Fibrosis

✍ Trapnell, Bruce; Maguiness, Karen M.; Graff, Gavin R.; Boyd, David; Caras, Steve 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Randomised clinical trial: the efficacy

Randomised clinical trial: the efficacy and safety of pancreatin enteric-coated minimicrospheres (Creon 40000 MMS) in patients with pancreatic exocrine insufficiency due to chronic pancreatitis - a double-blind, placebo-controlled study

✍ V. Thorat; N. Reddy; S. Bhatia; A. Bapaye; J. S. Rajkumar; D. D. Kini; M. M. Kal 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 253 KB

Efficacy and tolerability of a new formu

Efficacy and tolerability of a new formulation of pancrelipase delayed-release capsules in children aged 7 to 11 years with exocrine pancreatic insufficiency and cystic fibrosis: A multicenter, randomized, double-blind, placebo-controlled, two-period crossover, superiority study

✍ Gavin R. Graff; Karen Maguiness; John McNamara; Ronald Morton; David Boyd; Katri 📂 Article 📅 2010 🏛 Elsevier Science 🌐 English ⚖ 307 KB